Electrochemical biosensor for quantitation of anti-DNA autoantibodies in human serum

被引:16
|
作者
Rubin, Robert L. [1 ]
Wall, David [2 ]
Konstantinov, Konstantin N. [3 ]
机构
[1] Univ New Mexico Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA
[2] Voss Sci, Albuquerque, NM USA
[3] Univ New Mexico Hlth Sci Ctr, Div Rheumatol, Dept Internal Med, Albuquerque, NM 87131 USA
来源
关键词
Electrochemical flow-through biosensor; Anti-DNA autoantibody; Human serum; REVISED CRITERIA; ANTIBODIES; SURFACE; CLASSIFICATION; POINT;
D O I
10.1016/j.bios.2013.07.041
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Measurement of serum autoantibody is a critical tool in the diagnosis and management of autoimmune diseases. However, rapid and convenient methods at the point-of care have not been achieved in large part because any one antibody species is a heterogeneous and miniscule fraction of the total serum immunoglobulin displaying identical properties other than its antigen-binding specificity. The present system addresses these challenges by vacuum-mediated transport of diluted serum through an antigen-coated porous membrane. To measure anti-DNA autoantibodies, native DNA was immobilized into a poly (vinylidene fluoride) membrane pre-coated with a synthetic phenylalanine/lysine co-polymer. Flow-through of primary and peroxidase-conjugated secondary antibodies over the course of 3 min enhanced productive antibody-antigen interactions by bringing the reactants into close mutual proximity. Signal was quantified electrochemically during the enzymatic conversion of the tetramethylbenzidine substrate to a charge-transfer complex. The electrochemical signals generated by sera from patients with systemic lupus erythematosus using this device showed good quantitative correlation with a standard enzyme-linked immunosorbent assay and displayed similar detection limits. Inter- and intra-assay variability and electrode uniformity were favorable as was a two-month test of the stability of the DNA-coated membrane. While refining the fluidics requirements of this biosensor will be needed, its capacity to quantify over the course of 30 min anti-DNA antibodies in fresh human serum without background reactivity of normal serum makes this a promising technology as a point-of care device of clinical utility. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:177 / 183
页数:7
相关论文
共 50 条
  • [1] Anti-DNA and autoantibodies
    Pisetsky, DS
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (05) : 364 - 368
  • [2] ORIGINS OF ANTI-DNA AUTOANTIBODIES
    SCHWARTZ, RS
    STOLLAR, BD
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (02): : 321 - 327
  • [3] Intricacies of anti-DNA autoantibodies
    Radic, MZ
    Weigert, M
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (06): : 3367 - 3367
  • [4] FINE ANTIGENIC SPECIFICITY OF CIRCULATING HUMAN ANTI-DNA AUTOANTIBODIES
    ALAM, K
    ALI, A
    ALI, R
    [J]. MEDICAL SCIENCE RESEARCH, 1995, 23 (01): : 39 - 40
  • [5] SHARED IDIOTYPES ARE EXPRESSED ON MOUSE AND HUMAN ANTI-DNA AUTOANTIBODIES
    MORGAN, A
    ISENBERG, DA
    NAPARSTEK, Y
    RAUCH, J
    DUGGAN, D
    KHIROYA, R
    STAINES, NA
    SCHATTNER, A
    [J]. IMMUNOLOGY, 1985, 56 (03) : 393 - 399
  • [6] ORIGIN OF ANTI-DNA AUTOANTIBODIES IN SLE
    WINKLER, TH
    KALDEN, JR
    [J]. LUPUS, 1994, 3 (02) : 75 - 76
  • [7] GENETIC ORIGINS OF ANTI-DNA AUTOANTIBODIES
    EILAT, D
    [J]. ANNALES DE MEDECINE INTERNE, 1990, 141 (03): : 205 - 207
  • [8] Rapid detection of anti-chromatin autoantibodies in human serum using a portable electrochemical biosensor
    Konstantinov, Konstantin N.
    Sitdikov, Ravil A.
    Lopez, Gabriel P.
    Atanassov, Plamen
    Rubin, Robert L.
    [J]. BIOSENSORS & BIOELECTRONICS, 2009, 24 (07): : 1949 - 1954
  • [9] A potential immunogen responsible for producing human lupus anti-DNA autoantibodies
    Hirabayashi, Y.
    Oka, Y.
    Takasawa, N.
    Takahashi, R.
    Ishii, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 307 - 307
  • [10] Anti-DNA autoantibodies and systemic lupus erythematosus
    Blatt, NB
    Glick, GD
    [J]. PHARMACOLOGY & THERAPEUTICS, 1999, 83 (02) : 125 - 139